Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$432,733
-$16,931 QoQ
Shares Held
1,195
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,275
of 3,140 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACKSON SQUARE CAPITAL, LLC holds $34,281,243 across 7 Drug Manufacturers - General names. AMGN ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,872 | $22,635,644 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,686 | $4,457,151 | |
| 3 | ABBV |
AbbVie Inc.
|
14,566 | $3,665,388 | |
| 4 | JNJ |
Johnson & Johnson
|
7,767 | $1,972,584 | |
| 5 | NVS |
Novartis AG
|
3,643 | $570,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,490 | $546,813 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,195 | $432,733 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,733 | 1,195 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $449,664 | 1,278 | Shares | Sole | 2026-04-13 | |
| 2020-09-30 | $66,335 | 261 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $61,559 | 261 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $59,197 | 292 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||